|Year : 2020 | Volume
| Issue : 3 | Page : 161-164
Massive citalopram overdose associated with recurrent seizures and bilateral shoulder dislocations
Shafeajafar Zoofaghari1, Anselm Wong2, Pegah Kiarasi3, Farzad Gheshlaghi1
1 Department of Clinical Toxicology, Isfahan Clinical Toxicology Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Emergency Department, Austin Toxicology Unit, Victorian Poisons Information Centre, Austin Health; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University; Department of Medicine and Radiology, Centre for Integrated Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia
3 Department of Clinical Toxicology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
|Date of Submission||27-Apr-2020|
|Date of Acceptance||18-Jun-2020|
|Date of Web Publication||08-Oct-2020|
Dr. Farzad Gheshlaghi
Department of Clinical Toxicology, Isfahan Clinical Toxicology Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan
Source of Support: None, Conflict of Interest: None
Selective serotonin reuptake inhibitors (SSRIs) are widely used in the treatment of many types of mental disorders. Citalopram is commonly used as a new generation of SSRIs in this regard; however, unfortunately, its overdose is associated with seizure and heart disorders. The reported case in the present study indicated recurrent seizures, nonspecific ST-T changes, and prolonged QT interval due to the overuse of citalopram. The patient had bilateral anterior shoulder dislocation along with right proximal humerus fracture that was occurred during the seizure. The dislocation was initially reduced and then fixed. Moreover, the seizure was controlled with diazepam without any problems, and cardiac monitoring continued for 2 days. Massive citalopram overdose may be associated with recurrent seizures and QT prolongation. Complications postseizures, such as shoulder dislocations, should be examined for and managed appropriately.
Keywords: Citalopram, seizure, shoulder dislocation
|How to cite this article:|
Zoofaghari S, Wong A, Kiarasi P, Gheshlaghi F. Massive citalopram overdose associated with recurrent seizures and bilateral shoulder dislocations. J Res Pharm Pract 2020;9:161-4
|How to cite this URL:|
Zoofaghari S, Wong A, Kiarasi P, Gheshlaghi F. Massive citalopram overdose associated with recurrent seizures and bilateral shoulder dislocations. J Res Pharm Pract [serial online] 2020 [cited 2021 May 17];9:161-4. Available from: https://www.jrpp.net/text.asp?2020/9/3/161/297563
| Introduction|| |
Citalopram is a selective serotonin reuptake inhibitor (SSRI) that has comparable or greater efficacy than other SSRIs and tricyclic antidepressants (TCAs). Citalopram acts by inhibiting the neuronal reabsorption of serotonin with minimal effect on norepinephrine and dopamine. The usual dose of citalopram is 20–40 mg daily. Overdose of the mentioned drug is associated with symptoms and signs such as dizziness, sweating, nausea, vomiting, tremor, drowsiness, and sinus tachycardia. In previous studies, a generalized seizure was reported in 2%–6% of patients who referred to the hospital following the overdose of citalopram., The onset of seizures may occur within an hour after overdosing or may be delayed up to 13 h later., The mechanism of seizure following citalopram poisoning is unclear; however, a surge increase in cerebral serotonin concentration may be directly responsible in this regard. We describe a case of recurrent seizures following citalopram overdose complicated by bilateral shoulder dislocations and fractures.
| Case Report|| |
A 33-year-old male patient presented with a chief complaint of drowsiness referred to the poisoning department of Khorshid Hospital, Isfahan, Iran. He had a history of taking 40 tablets of citalopram (40 mg) an hour before admission to the hospital with the intention of committed suicide. On arrival, he was conscious with a blood pressure of 100 / 70 mmHg, respiratory rate 18/min, heart rate 86 bpm, SpO2 99% on room air, and temperature 37°C. Other laboratory data (after seizure) are presented in [Table 1].
|Table 1: Patient's laboratory data at the time of admission to the toxicological emergencies department|
Click here to view
Shortly after admission, he developed a generalized tonic-clonic seizure that lasted 2 min and resolved without treatment. Nonspecific ST-T changes and prolonged QT interval were observed in the electrocardiogram strip recorded.
After becoming conscious, the nasogastric tube was inserted, and gastric lavage and charcoal therapy were performed. The clinical examination revealed that the right shoulder was dislocated. Portable X-ray were taken, and bilateral anterior shoulder dislocation along with right proximal humerus fracture was confirmed [Figure 1]a.
|Figure 1: Right proximal humerus fracture dislocation before (a) and after (b) reduction|
Click here to view
One hour later, the patient again had a second tonic-clonic seizure that was controlled with diazepam. The patient was sedated and intubated because of decreased level of consciousness, risk of aspiration, and decreased O2 saturation. The patient was transferred to the intensive care unit and underwent mechanical ventilation. Brain computed tomography (CT) scan was done for rule out of central nervous system problem then under sedation, right shoulder dislocation was reduced [Figure 1]b.
The brain CT scan was normal. The patient was discharged with full recovery after 2 days and referred to the orthopedic and psychiatric departments for follow-up [Figure 2].
|Figure 2: Timeline of the patient's medical status after admission to the toxicological emergencies department|
Click here to view
| Discussion|| |
In previous studies, seizures were reported in 6% of patients following the overdose of citalopram,, but recurrent seizures were very rarely reported. The onset of seizures may occur within an hour after overdosing or may be delayed up to 13 h later. The mechanism of seizure following citalopram poisoning is uncertain. However, a rush in cerebral serotonin concentration may be directly responsible in this regard. The recurrence of seizures may be dose related.
QT prolongation, which may predispose to Torsades de pointes (TdP), can also occur with citalopram overdose. Previous studies suggest that the administration of activated charcoal might help decrease the risk of QT prolongation and subsequent TdP. The proportion of those at risk of TdP (using the QT nomogram) who received activated charcoal was half that of those who did not receive activated charcoal, presumably because of decreased citalopram absorption. Therefore, early activated charcoal may also be useful at decreasing the risk of seizures. However, in our case, a seizure had already occurred, which could reflect the ongoing absorption of the massive citalopram ingestion.
Monitoring should occur for at least 13 h postoverdose for the risk of developing QT prolongation and seizures.
SSRIs are generally safer than older antidepressants, such as TCAs and monoamine oxidase inhibitors. In addition to the low toxicity of SSRIs, their effectiveness in the treatment of many mental disorders has led to their widespread use. However, an overdose of the SSRIs, including citalopram, may be associated with complications such as tachycardia, drowsiness, tremor, nausea, and vomiting.
Cardiac toxicity and seizure were reported as the rare complications of citalopram overdose. Our case had a recurrent seizure, with nonspecific ST-T changes and prolonged QT interval. The patient reported in Cuenca et al.'s study presented with seizure and episode of supraventricular tachycardia following the overdose of citalopram. In 6 cases of fatal citalopram overdose cardiac dysrhythmia or seizure suggested as probable causes of death. In another study, citalopram overdose led to the generalized seizure and cardiac disorder in six patients. Some of the cardiac disorders included prolonged QT interval, transient sinus tachycardia, and inferolateral ST-T changes.
Cuenca et al. stated that seizure incidents increase the need for invasive ventilatory support, secondary trauma, and increase hospital stay. For these complications, patients with citalopram overdose must be observed at least 24 h postingestion.
| Conclusion|| |
Massive citalopram overdose may be complicated with recurrent seizures and QT prolongation. Complications postseizure consequences, such as shoulder dislocations, should be assessed and managed appropriately. Early administration of activated charcoal should be considered to decrease the risk of toxicity.
Declaration of patient consent
The authors certify that they have obtained appropriate patient consent forms. In the form, the patient has given his consent for his clinical information to be reported. He understood that his name would not be published, and outstanding efforts will be made to conceal his identity.
| Authors' Contribution|| |
Shafeajafar Zoofaghari and Farzad Gheshlaghi contributed to the idea and design of the study. Shafeajafar Zoofaghari and Pegah Kiarasi gathered the data. Shafeajafar Zoofaghari. Farzad Gheshlaghi and Anselm Wong drafted the manuscript, and all authors critically revised it for relevant intellectual content and approved the final version.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Waring WS, Gray JA, Graham A. Predictive factors for generalized seizures after deliberate citalopram overdose. Br J Clin Pharmacol 2008;66:861-5.
Nemeroff CB. Overview of the safety of citalopram. Psychopharmacol Bull 2003;37:96-121.
Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004;42:277-85.
Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 2004;42:67-71.
Cuenca PJ, Holt KR, Hoefle JD. Seizure secondary to citalopram overdose. J Emerg Med 2004;26:177-81.
Masullo LN, Miller MA, Baker SD, Bose S, Levsky M. Clinical course and toxicokinetic data following isolated citalopram overdose in an infant. Clin Toxicol (Phila) 2006;44:165-8.
Godlewska BR, Norbury R, Selvaraj S, Cowen PJ, Harmer CJ. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. Psychol Med 2012;42:2609-17.
Personne M, Sjöberg G, Persson H. Citalopram overdose – Review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol 1997;35:237-40.
Oström M, Eriksson A, Thorson J, Spigset O. Fatal overdose with citalopram. Lancet (London, England) 1996;348:339.
[Figure 1], [Figure 2]